reports
Ontex Group NV: 1 director
A director at Ontex Group NV bought 5,000 shares at 4.630EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Robert Jan Vos
- Usama Tariq
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Livio Luyten
- Michiel Declercq
- Thibault Leneeuw
- Wim Lewi
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 11 December 2025 to 17 December 2025 Share Buyback ProgramOn , Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 25 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 11 December 2025 to 17 December 2025, Kepler Cheuvreux SA on behalf of Bekaert has bought 50 000 shares. Th...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquid...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 11 december 2025 tot 17 december 2025 Inkoopprogramma van Eigen AandelenOp , kondigde Bekaert de start aan van de volgende tranche van haar inkoopprogramma, voor een totaalbedrag van maximaal € 25 miljoen. Zoals eerder aangekondigd heeft het inkoopprogramma tot doel alle ingekochte aandelen te vernietigen. Bekaert kondigt vandaag aan dat gedurende de periode van 11 december 2025 tot 17 december 2025, Kepler...
Bekaert: Transparency Law
Bekaert: Transparency Law Transparency LawDisclosure in accordance with the Law of 2 May 2007 Pursuant to Articles 15 §1 and 18 §1 of the Law of 2 May 2007 on the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market, NV Bekaert SA (“Bekaert”) publishes the following information: Status as of 15 December 2025 Basic data Total capital: € 159 782 000.00 Total number of securities conferring voting rights: 51 315 868 shares Total number of voting rights (the denominator): 51 315 868 (one voting right per share) Rea...
Bekaert: Transparantiewetgeving
Bekaert: Transparantiewetgeving TransparantiewetgevingOpenbaarmaking conform de Wet van 2 mei 2007 Conform artikelen 15 §1 en 18 §1 van de Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in emittenten waarvan aandelen zijn toegelaten tot de verhandeling op een gereglementeerde markt maakt NV Bekaert SA (“Bekaert”) volgende informatie bekend: Toestand op 15 december 2025 Basisgegevens Totaal kapitaal: € 159 782 000,00 Totaal aantal stemrechtverlenende effecten: 51 315 868 aandelen Totaal aantal stemrechten (de noemer): 51 315 868 (één st...
Fagron versnelt globale expansie met twee strategische overnames en ve...
Fagron versnelt globale expansie met twee strategische overnames en verkrijgt belangrijke licentie in Noord Amerika Gereglementeerde informatie - voorkennisNazareth (België)/Rotterdam (Nederland), 19 december 2025 – 7:00 AM CET Fagron versnelt globale expansie met twee strategische overnames en verkrijgt belangrijke licentie in Noord Amerika Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, is verheugd om twee strategische overnames aan te kondigen. Deze overnames helpen om onze globale aanwezigheid verder te versterken en capaciteiten te diversifiëren...
Fagron accelerates global expansion with two strategic acquisitions an...
Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 – 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone Fagron, the leading global player in pharmaceutical compounding, is pleased to announce two strategic acquisitions that further strengthen its global footprint and diversify its capabilities. These transactions include Amber Compounding Pharmacy, a...
Solvay Financial Calendar 2026
Solvay Financial Calendar 2026 Press release Regulated information Brussels, December 17, 2025, 5.45pm CET Solvay today publishes its 2026 financial calendar. EventDateInterim dividend: ex-dateJanuary 19, 2026Interim dividend: payment dateJanuary 21, 2026Fourth quarter and full year 2025 earnings February 24, 2026First quarter 2026 earnings May 7, 2026Ordinary General Shareholders’ MeetingMay 12, 2026Second quarter and first half year 2026 earnings July 29, 2026Third quarter and first nine months 2026 earnings November 4, 20...
Calendrier financier de Solvay en 2026
Calendrier financier de Solvay en 2026 Communiqué de presse Information réglementée Bruxelles, le 17 décembre 2025 - 17h45 CET Solvay publie aujourd’hui son calendrier financier pour 2026. ÉvénementDateDividende intérimaire: ex-date19 janvier 2026Dividende intérimaire: date de paiement21 janvier 2026Résultats du quatrième trimestre et de l’année 202524 février 2026Résultats du premier trimestre 20267 mai 2026Assemblée générale ordinaire des actionnaires12 mai 2026Résultats du deuxième trimestre et du premier semestre 202629 j...
Financiële kalender van Solvay in 2026
Financiële kalender van Solvay in 2026 Persbericht Gereglementeerde informatie Brussel, 17 december 2025, 17u45 CET Solvay publiceert vandaag zijn financiële kalender voor 2026. Evenement Datum Interimdividend: ex-coupon datum 19 januari 2026 Interimdividend: datum van betaling 21 januari 2026 Resultaten voor het vierde kwartaal en jaar 2025 24 februari 2026 Resultaten eerste kwartaal 2026 7 mei 2026 Gewone algemene aandeelhoudersvergadering 12 mei 2026 Resultaten tweede kwartaal e...
- Guy Sips
- Kristof Samoy
- Kristof Samoy
CMB.Tech Investment in Chinese ammonia supply
CMB.TECH is investing in the Chinese ammonia supply chain and signed an off-take agreement for green ammonia produced by CEEC in the Jilin Province and will own a minority share in privately owned Andefu, one of China's largest ammonia supply chain companies. While CMB.TECH did not disclose any financials on the deal we estimate linked financials are relatively small. CMB.TECH has a sensible but disciplined investment approach towards decarbonisation. Through the offtake agreement and terminal o...
CMB.TECH INVESTS IN CHINESE AMMONIA SUPPLY
CMB.TECH INVESTS IN CHINESE AMMONIA SUPPLY Antwerp, Dec. 16, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMBT”, “CMB.TECH” or “the Company”) is pleased to announce the company is investing in the Chinese ammonia supply chain. CMB.TECH has signed an off-take agreement for green ammonia produced by CEEC Hydrogen Energy (“CEEC”) in Jilin Province and will own a minority share in privately owned Jiangsu Andefu Energy Technology Co., Ltd. (“Andefu”) one of China's largest ammonia supply chain companies. Green ammonia produced...
Participation notification by UBS Group AG
Participation notification by UBS Group AG Press release Regulated informationBrussels, December 15, 2025, 17:45 CET In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. Here is a summary of the notification: Voting rights after the transactionEquivalent financial instruments after the transactionTotalPrevious0.17%2.88%3.05%New0.17%3.20%3.37% The notification, dated December 10, 2025...
Notification de participation par UBS Group AG
Notification de participation par UBS Group AG Communiqué de presse Information réglementée Bruxelles, le 15 décembre 2025 - 17h45 CET Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), UBS Group AG a envoyé récemment à Solvay la notification de transparence suivante, indiquant avoir franchi le seuil de 3%. Voici un résumé de la notification: Droits de vote après la transaction Instruments financiers équivalents après la transaction Total...
Participatiemelding van UBS Group AG
Participatiemelding van UBS Group AG Persbericht Gereglementeerde informatie Brussel, 15 december 2025 - 17u45 CET In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft UBS Group AG onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 3% heeft overschreden. Hier is een samenvatting van de beweging: Stemrechten na de transactie Aan stemrechten gelijkgestelde financiële instrumenten na de transactie Totaal Vor...
- Hilde Van Boxstael
- Jacob Mekhael
- Livio Luyten
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Wim Hoste
Ontex Model update post profit warning
Ontex issued a severe profit warning which implies the company now expects 4Q25 adjusted EBITDA to land at € 38-43m vs a previous expectation range of € 63-68m, with the downwards revision due to intense competition from A-brands in the baby care segment. We have reduced our adjusted EBITDA forecasts for FY25-27 by between 8-10%, but still expect FY26 EBITDA to grow by c. 12% vs our new FY25 forecast, on a combination of efficiency measures, the full contribution of new contracts and (at some po...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.